| Product Code: ETC7536740 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Angioedema Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 India Angioedema Market - Industry Life Cycle |
3.4 India Angioedema Market - Porter's Five Forces |
3.5 India Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 India Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 India Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 India Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 India Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 India Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about angioedema among healthcare professionals and patients |
4.2.2 Rising prevalence of angioedema in India |
4.2.3 Technological advancements in diagnostic tools and treatments for angioedema |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for angioedema diagnosis and treatment in certain regions of India |
4.3.2 High cost associated with angioedema treatments and medications |
4.3.3 Lack of comprehensive insurance coverage for angioedema treatments in India |
5 India Angioedema Market Trends |
6 India Angioedema Market, By Types |
6.1 India Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 India Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 India Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 India Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 India Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 India Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 India Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 India Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 India Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 India Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 India Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 India Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 India Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 India Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 India Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 India Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 India Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 India Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 India Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 India Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 India Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 India Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 India Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 India Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 India Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 India Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 India Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 India Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 India Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 India Angioedema Market Import-Export Trade Statistics |
7.1 India Angioedema Market Export to Major Countries |
7.2 India Angioedema Market Imports from Major Countries |
8 India Angioedema Market Key Performance Indicators |
8.1 Number of healthcare professionals attending angioedema awareness programs |
8.2 Percentage increase in angioedema diagnosis rates in India |
8.3 Adoption rate of advanced diagnostic tools for angioedema among healthcare facilities |
8.4 Patient satisfaction levels with angioedema treatment options and services |
8.5 Number of research studies and clinical trials focused on angioedema in India |
9 India Angioedema Market - Opportunity Assessment |
9.1 India Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 India Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 India Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 India Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 India Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 India Angioedema Market - Competitive Landscape |
10.1 India Angioedema Market Revenue Share, By Companies, 2024 |
10.2 India Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here